ArticleESMO gastrointestinal oncology2026

Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].

A Gandini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.